LPS-mediated NFκB activation varies between activated human hepatic stellate cells from different donors

Biochemical and Biophysical Research Communications

Volumn 325, Issue 1, 2004, Pages 191-197

  Mühlbauer, Marcus ^a   Weiss, Thomas S ^a   Thasler, Wolfgang E ^a,b   Gelbmann, Cornelia M ^a   Schnabl, Bernd ^a   Schölmerich, Jürgen ^a   Hellerbrand, Claus ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

Author keywords

Chemokines; Endotoxin; Heptic stellate cells; IL 8; LPS; NF B

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 8; LIPOPOLYSACCHARIDE;

ARTICLE; CELL ACTIVATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE RELEASE; HUMAN; HUMAN CELL; LIVER CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; STELLATE CELL; CELL CULTURE; CULTURE TECHNIQUE; CYTOLOGY; DONOR; DOSE RESPONSE; FIBROSIS; IMMUNOLOGY; INFLAMMATION; LIVER; LIVER DISEASE; METABOLISM; METHODOLOGY; PATHOLOGY;

CELL CULTURE TECHNIQUES; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; FIBROSIS; HUMANS; INFLAMMATION; INTERLEUKIN-8; LIPOPOLYSACCHARIDES; LIVER; LIVER DISEASES; NF-KAPPA B; TISSUE DONORS;

EID: 7444246128     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2004.10.020     Document Type: Article

References (36)

1. M.L. Hautekeete, and A. Geerts The hepatic stellate (Ito) cell: its role in human liver disease Virchows Arch. 430 1997 195 207
2. R. Bataller, and D.A. Brenner Hepatic stellate cells as a target for the treatment of liver fibrosis Semin. Liver Dis. 21 2001 437 451
3. H.L. Reeves, and S.L. Friedman Activation of hepatic stellate cells-a key issue in liver fibrosis Front. Biosci. 7 2002 d808 d826
4. T. Poynard, P. Bedossa, and P. Opolon Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups Lancet 349 1997 825 832
5. R. Bataller, K.E. North, and D.A. Brenner Genetic polymorphisms and the progression of liver fibrosis: a critical appraisal Hepatology 37 2003 493 503
6. M. Mühlbauer, A.K. Bosserhoff, A. Hartmann, W.E. Thasler, T.S. Weiss, H. Herfarth, G. Lock, J. Schölmerich, and C. Hellerbrand A novel MCP-1 gene polymorphism is associated with hepatic MCP-1 expression and severity of HCV-related liver disease Gastroenterology 125 2003 1085 1093
7. H. Tsukamoto, and S.C. Lu Current concepts in the pathogenesis of alcoholic liver injury FASEB J. 15 2001 1335 1349
8. R.J. Ulevitch, and P.S. Tobias Recognition of gram-negative bacteria and endotoxin by the innate immune system Curr. Opin. Immunol. 11 1999 19 22
9. A.B. Lumsden, J.M. Henderson, and M.H. Kutner Endotoxin levels measured by a chromogenic assay in portal, hepatic and peripheral venous blood in patients with cirrhosis Hepatology 8 1988 232 236
10. S.M. Riordan, N. Skinner, A. Nagree, H. McCallum, C.J. McIver, J. Kurtovic, J.A. Hamilton, S. Bengmark, R. Williams, and K. Visvanathan Peripheral blood mononuclear cell expression of toll-like receptors and relation to cytokine levels in cirrhosis Hepatology 37 2003 1154 1164
11. C.A. Rivera, B.U. Bradford, V. Seabra, and R.G. Thurman Role of endotoxin in the hypermetabolic state after acute ethanol exposure Am. J. Physiol. 275 1998 G1252 G1258
12. Y.H. Paik, R.F. Schwabe, R. Bataller, M.P. Russo, C. Jobin, and D.A. Brenner Toll-like receptor 4 mediates inflammatory signaling by bacterial lipopolysaccharide in human hepatic stellate cells Hepatology 37 2003 1043 1055
13. M. Karin, and A. Lin NF-kappaB at the crossroads of life and death Nat. Immunol. 3 2002 221 227
14. C. Hellerbrand, C. Jobin, L.L. Licato, R.B. Sartor, and D.A. Brenner Cytokines induce NF-kappaB in activated but not in quiescent rat hepatic stellate cells Am. J. Physiol. 275 1998 G269 G278
15. C. Hellerbrand, C. Jobin, Y. Iimuro, L. Licato, R.B. Sartor, and D.A. Brenner Inhibition of NFkappaB in activated rat hepatic stellate cells by proteasome inhibitors and an IkappaB super-repressor Hepatology 27 1998 1285 1295
16. A. Lang, R. Schoonhoven, S. Tuvia, D.A. Brenner, and R.A. Rippe Nuclear factor kappaB in proliferation, activation, and apoptosis in rat hepatic stellate cells J. Hepatol. 33 2000 49 58
17. M.C. Wright, R. Issa, D.E. Smart, N. Trim, G.I. Murray, J.N. Primrose, M.J. Arthur, J.P. Iredale, and D.A. Mann Gliotoxin stimulates the apoptosis of human and rat hepatic stellate cells and enhances the resolution of liver fibrosis in rats Gastroenterology 121 2001 685 698
18. Y.O. Kweon, Y.H. Paik, B. Schnabl, T. Qian, J.J. Lemasters, and D.A. Brenner Gliotoxin-mediated apoptosis of activated human hepatic stellate cells J. Hepatol. 39 2003 38 46
19. J.P. Iredale Hepatic stellate cell behavior during resolution of liver injury Semin. Liver Dis. 21 2001 427 436
20. T.S. Weiss, B. Jahn, M. Cetto, K.W. Jauch, and W.E. Thasler Collagen sandwich culture affects intracellular polyamine levels of human hepatocytes Cell Prolif. 35 2002 257 267
21. Hellerbrand, S.C. Wang, H. Tsukamoto, D.A. Brenner, and R.A. Rippe Expression of intracellular adhesion molecule 1 by activated hepatic stellate cells Hepatology 24 1996 670 676
22. I. Sylvester, A.F. Suffredini, A.J. Boujoukos, G.D. Martich, R.L. Danner, T. Yoshimura, and E.J. Leonard Neutrophil attractant protein-1 and monocyte chemoattractant protein-1 in human serum. Effects of intravenous lipopolysaccharide on free attractants, specific IgG autoantibodies and immune complexes J. Immunol. 151 1993 3292 3298
23. M.N. Devalaraja, C.J. Mcclain, S. Barve, K. Vaddi, and D.B. Hill Increased monocyte MCP-1 production in acute alcoholic hepatitis Cytokine 11 1999 875 881
24. P. Renard, I. Ernest, A. Houbion, M. Art, H. Le Calvez, M. Raes, and J. Remacle Development of a sensitive multi-well colorimetric assay for active NFkappaB Nucleic Acids Res. 29 2001 E21
25. H. Sprenger, A. Kaufmann, H. Garn, B. Lahme, D. Gemsa, and A.M. Gressner Differential expression of monocyte chemotactic protein-1 (MCP-1) in transforming rat hepatic stellate cells J. Hepatol. 30 1999 88 94
26. R.F. Schwabe, B. Schnabl, Y.O. Kweon, and D.A. Brenner CD40 activates NF-kappa B and c-Jun N-terminal kinase and enhances chemokine secretion on activated human hepatic stellate cells J. Immunol. 166 2001 6812 6819
27. A. Albini, B. Pontz, M. Pulz, G. Allavena, H. Mensing, and P.K. Muller Decline of fibroblast chemotaxis with age of donor and cell passage number Collagen Relat. Res. 8 1988 23 37
28. T. Pap, U. Muller-Ladner, R.E. Gay, and S. Gay Fibroblast biology. Role of synovial fibroblasts in the pathogenesis of rheumatoid arthritis Arthritis Res. 2 2000 361 367
29. J.R. Smith, S. Venable, T.W. Roberts, E.J. Metter, R. Monticone, and E.L. Schneider Relationship between in vivo age and in vitro aging: assessment of 669 cell cultures derived from members of the Baltimore Longitudinal Study of Aging J. Gerontol. A Biol. Sci. Med. Sci. 57 2002 B239 B246
30. P. Olinga, M. Merema, G.W. Sandker, M.J. Slooff, D.K. Meijer, and G.M. Groothuis Uptake of taurocholic acid in human hepatocytes isolated from livers of donors of different age J. Pediatr. Gastroenterol. Nutr. 27 1998 366 368
31. P. Olinga, M. Merema, I.H. Hof, K.P. de Jong, M.J. Slooff, D.K. Meijer, and G.M. Groothuis Effect of human liver source on the functionality of isolated hepatocytes and liver slices Drug Metab. Dispos. 26 1998 5 11
32. P.A. Baeuerle, and T. Henkel Function and activation of NF-kappa B in the immune system Annu. Rev. Immunol. 12 1994 141 179
33. H.L. Reeves, A.D. Burt, S. Wood, and C.P. Day Hepatic stellate cell activation occurs in the absence of hepatitis in alcoholic liver disease and correlates with the severity of steatosis J. Hepatol. 25 1996 677 683
34. T. Masumoto, K. Ohkubo, K. Yamamoto, T. Ninomiya, M. Abe, S.M. Akbar, K. Michitaka, N. Horiike, and M. Onji Serum IL-8 levels and localization of IL-8 in liver from patients with chronic viral hepatitis Hepatogastroenterology 45 1998 1630 1634
35. A.M. Elsharkawy, M.C. Wright, R.T. Hay, M.J. Arthur, T. Hughes, M.J. Bahr, K. Degitz, and D.A. Mann Persistent activation of nuclear factor-kappaB in cultured rat hepatic stellate cells involves the induction of potentially novel Rel-like factors and prolonged changes in the expression of IkappaB family proteins Hepatology 30 1999 761 769
36. S.L. Friedman Liver fibrosis-from bench to bedside J. Hepatol. 38 Suppl. 1 2003 S38 S53